A New Triazine-Based Tricompartmental Ligand for Stepwise Assembly of Mononuclear, Dinuclear, and 1D-Polymeric Heptacoordinate Manganese(II)/Azido Complexes

Recent developments in supramolecular complexes of azabenzenes containing one to four N atoms: synthetic strategies, structures, and magnetic properties

For the last couple of decades, azabenzene-based ligands have drawn much attention from inorganic chemists due to their ability to coordinate with different metal ions to form supramolecular clusters. These azabenzenes are weak σ donors and strong π acceptors and electron-deficient. Metallogrid complexes and non-grid oligomers are well-defined supramolecular clusters, formed by appropriate chelating ligands, and can show interesting optical, magnetic, and electronic properties. Self-assembly of [n × n] metallogrid complexes is dominated by the entropic factor while the formation of oligonuclear metal ion complexes is dominated by other effects like CFSE, electrostatic factors, ligand conformational characters, etc. Herein, the present article gives an overview of six-membered heterocyclic azine-based ligands and their potential for different metal ions to form polynuclear complexes. Moreover, their temperature-dependent magnetic properties and SCO phenomena are well described and tabulated.

X-ray Structure Analyses and Biological Evaluations of a New Cd(II) Complex with S-Triazine Based Ligand

The crystal structure of a new penta-coordinated Cd(II) complex of the formula [Cd(BPMT)Br2] was presented. This Cd(II) complex was synthesized by mixing Cd(NO3)2·4H2O and 2,4-bis(3,5-dimethyl-1H-pyrazol-1-yl)-6-methoxy-1,3,5-triazine (BPMT) in the presence of KBr. It crystallized in the monoclinic crystal system and P21/n space group. The crystal parameters are a = 11.3680(8) Å, b = 11.1648(8) Å, c = 15.8593(11) Å, and β = 103.563(2)°, while the unit cell volume is 2190.6(12) Å3 and it comprised four molecules. The supramolecular structure of the [Cd(BPMT)Br2] complex is mainly controlled by the intermolecular Br∙∙∙H interactions. Hirshfeld calculations predicted the H∙∙∙H (38.1%), Br∙∙∙H (24.3%), C∙∙∙H (11.1%), and N∙∙∙H (9.5%) interactions are the most dominant. Biological evaluations for the antimicrobial and anticancer properties of the studied complex are presented. The Cd(II) complex has better anticancer and antibacterial activities than the free BPMT ligand. The anticancer activity against lung carcinoma (A-549) is higher for the former (18.64 ± 1.09 µg/mL) compared to the latter (372.79 ± 13.64 µg/mL). Additionally, the best antibacterial activity for the Cd(II) complex was found against B. subtilis.

Synthesis, X-ray Structure and Biological Studies of New Self-Assembled Cu(II) Complexes Derived from s-triazine Schiff Base Ligand

The two ligands 2-(1-(2-(4,6-dimorpholino-1,3,5-triazin-2-yl)hydrazono)ethyl)aniline (DMAT) and 2-(1-(2-(4,6-dimorpholino-1,3,5-triazin-2-yl)hydrazono)ethyl)phenol (DMOHT) were used to synthesize three heteroleptic Cu(II) complexes via a self-assembly technique. The structure of the newly synthesized complexes was characterized using elemental analysis, FTIR and X-ray photoelectron spectroscopy (XPS) to be [Cu(DMAT)(H2O)(NO3)]NO3.C2H5OH (1), [Cu(DMOT)(CH3COO)] (2) and [Cu(DMOT)(NO3)] (3). X-ray single-crystal structure of complex 1 revealed a hexa-coordinated Cu(II) ion with one DMAT as a neutral tridentate NNN-chelate, one bidentate nitrate group and one water molecule. In the case of complex 2, the Cu(II) is tetra-coordinated with one DMOT as an anionic tridentate NNO-chelate and one monodentate acetate group. The antimicrobial, antioxidant and anticancer activities of the studied compounds were examined. Complex 1 had the best anticancer activity against the lung carcinoma A-549 cell line (IC50 = 5.94 ± 0.58 µM) when compared to cis-platin (25.01 ± 2.29 µM). The selectivity index (SI) of complex 1 was the highest (6.34) when compared with the free ligands (1.3–1.8), and complexes 2 (0.72) and 3 (2.97). The results suggested that, among those compounds studied, complex 1 is the most promising anticancer agent against the lung carcinoma A-549 cell line. In addition, complex 1 had the highest antioxidant activity (IC50 = 13.34 ± 0.58 µg/mL) which was found to be comparable to the standard ascorbic acid (IC50 = 10.62 ± 0.84 µg/mL). Additionally, complex 2 showedbroad-spectrum antimicrobial action against the microbes studied. The results revealed it to possess the strongest action of all the three complexes against B. subtilis. The MIC values found are 39.06, 39.06 and 78.125 mg/mL for complexes 1–3, respectively.

Synthesis, Characterization, and Antimicrobial Studies of Novel Series of 2,4-Bis(hydrazino)-6-substituted-1,3,5-triazine and Their Schiff Base Derivatives

The present work represents the synthesis, characterization, and antimicrobial studies of novel series of 2,4-bis(hydrazino)-6-substituted-1,3,5-triazine and their Schiff base derivatives. IR, NMR (H1 and C13), elemental analysis, and LC-MS characterized the prepared compounds. The biological activity of the target products was evaluated as well. Twenty-two of the prepared compounds were selected according to their solubility in aqueous DMSO. Only eight compounds showed good activity against the selected pathogenic bacteria and did not show antagonistic effect against fungus Candida albicans. Two compounds 4k and 5g have wide-range effect presently in Gram-positive and Gram-negative bacteria while other compounds (4f, 4i, 4m, 5d, 6i, and 6h) showed specific effect against the Gram-negative or Gram-positive bacteria. The minimum inhibitory concentration (MIC, μg/mL) of 4f, 4i, 4k, and 6h compounds against Streptococcus mutans was 62.5 μg/mL, 100 μg/mL, 31.25 μg/mL, and 31.25 μg/mL, respectively. The MIC of 4m, 4k, 5d, 5g, and 6h compounds against Staphylococcus aureus was 62.5 μg/mL, 31.25 μg/mL, 31.25 μg/mL, 100 μg/mL, and 62.5 μg/mL, respectively. The MIC of 4k, 5g, and 6i compounds against Salmonella typhimurium was 31.25 μg/mL, 100 μg/mL, and 62.5 μg/mL, respectively. The MIC of 6i compound against Escherichia coli was 62.5 μg/mL.